PharmaShots | Incisive News in 3 Shots

Subscribe Now

Omni nuclease program

Takeda Signs a Licensing Option Agreement with Emendo Biotherapeutics for its OMNI Nuclease Program

Takeda Signs a Licensing Option Agreement with Emendo Biotherapeutics for its OMNI Nuclease Program

April 25, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us